A detailed history of Viking Global Investors LP transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 143,085,126 shares of DNA stock, worth $47.2 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
143,085,126
Previous 143,085,126 -0.0%
Holding current value
$47.2 Million
Previous $242 Million 31.36%
% of portfolio
0.63%
Previous 0.91%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$1.2 - $2.19 $96 Million - $175 Million
80,000,000 Added 126.81%
143,085,126 $190 Million
Q4 2022

Feb 14, 2023

SELL
$1.63 - $3.52 $63.2 Million - $136 Million
-38,749,000 Reduced 38.05%
63,085,126 $107 Million
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $54.6 Million - $280 Million
74,750,000 Added 275.99%
101,834,126 $318 Million
Q2 2022

Aug 15, 2022

SELL
$2.2 - $4.2 $52.7 Million - $101 Million
-23,971,018 Reduced 46.95%
27,084,126 $64.5 Million
Q1 2022

May 16, 2022

SELL
$2.83 - $8.69 $815 Million - $2.5 Billion
-288,000,000 Reduced 84.94%
51,055,144 $206 Million
Q4 2021

May 16, 2022

BUY
$8.31 - $14.92 $225 Million - $404 Million
27,084,126 Added 8.68%
339,055,144 $2.82 Billion
Q4 2021

Feb 14, 2022

SELL
$8.31 - $14.92 $225 Million - $404 Million
-27,084,126 Reduced 7.99%
311,971,018 $2.59 Billion
Q3 2021

May 16, 2022

BUY
$9.15 - $13.28 $330 Million - $480 Million
36,112,170 Added 11.92%
339,055,144 $3.93 Billion
Q3 2021

Nov 15, 2021

BUY
$9.15 - $13.28 $2.77 Billion - $4.02 Billion
302,942,974 New
302,942,974 $3.51 Billion

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $425M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Viking Global Investors LP Portfolio

Follow Viking Global Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Viking Global Investors LP with notifications on news.